6
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Effects of Endotoxin in Mice Bearing Solid Metastasizing Tumors and Treated with Lysozyme Hydrochloride

, , &
Pages 228-234 | Published online: 15 Jul 2016

References

  • Baldwin RW. Manipulation of host resistance in cancer therapy. Springer Semin Immunopathol 1982; 5: 113–125.
  • North RJ, Dye ES, Mills CD, Chandler JP. Modulation of antitumor immunity — immunobiologic approaches. Springer Semin Immunopathol 1982; 5: 193–220.
  • Sava G. Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme. Cancer Chemother Pharmacol 1989; 25: 221–222.
  • Sava G, Benetti A, Ceschia V, Pacor S. Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review). Anticancer Res 1989; 9: 583–592.
  • Sava G, Ceschia V, Zabucchi G. Evidence for hostmediated antitumor effects of lysozyme in mice bearing MCa mammary carcinoma. Eur J Cancer Clin Oncol 1988; 24: 1737–1743.
  • Sava G, Perissin L, Zorzet S. Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma. Clin Expl Metastasis 1988; 6: 245–253.
  • Reitano S, Kayhk K, Osserman EF. Human lysozyme induces proliferation of human periferal blood lymphocytes. Fed Proc 1982; 41: 608.
  • Rinehart JJ, Cerilli JG, Jacobs HS, Osserman EF. Lysozyme stimulates lymphocyte proliferation in monocyte depleted mixed lymphocyte cultures. J Lab Clin Med 1982; 99: 370–381.
  • Lemarbre P, Rinehart JJ, Kay NE, Vesella R.Jacob HS. Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killing. Blood 1981; 58: 994–999.
  • Sava G, Ceschia V, Pacor S. Mechanism of the antineoplastic action of lysozyme: evidence for host-mediated effects. Anticancer Res 1989; 9: 1175–1180.
  • Sava G, Ceschia V, Pacor S, Zorzet S, Perissin L. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. Meth Find Exp Clin Pharmacol 1989; 11: 683–689.
  • Fukawa K, Nishimura N, Irino O, Nitta K. Experimental studies on antitumor effects of lysozyme-II: Effects of lysozyme on immunopotentiation. Gan to Kagaku Ryoho 1982; 9: 1832–1837.
  • Cartei F, Cartei G, Ceschia V, Pacor S, Sava G. Clinical trial on the recovery of lymphocyte CD4 + /CD8 + ratio by lysozyme. Drug Invest 1992; 4: 51–57.
  • Ceschia V, Sava G, Gagliardi R, Zabucchi G. Effects of lysozyme on spleen and lungs in mice with Lewis lung carcinoma. Pharmacol Res Commun 1988; 20: 615–616.
  • Inouye K. The effects of lysozyme chloride on the immune response of patients with head and neck cancer. Gan No Rinsho 1987; 33: 627–632.
  • Namba Y, Hidaka Y, Taki K, Morimoto T. Effects of oral administration of lysozyme in guinea pig. Infect Immun 1981; 31: 580–583.
  • Ossermann EF, Klockars M, Halper J, Fischel RE. Effects of lysozyme on normal and transformed mammalian cells. Nature 1973; 243: 331–335.
  • Vacca A, Campobasso N, Iodice G, Ronco M, Dammacco F. Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma. Chemotherapy 1985; IV: 145–155.
  • Algire GH, Legallis FY, Park HD. Vascular reactions of normal and malignant tissues in vivo. II. The vascular reaction of normal and neoplastic tissues of mice to a bacterial polysaccharide from Serratia marcescens (bacillus prodigeousus) culture filtrates. J Natl Cancer Inst 1948; 8: 53.
  • Havell EA, Fiers W, North RJ. The antitumor function of tumor necrosis factor (TNF). I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med 1988; 167: 1067–1085.
  • North RJ, Havell EA. The antitumor function of tumor necrosis factor (TNF). II. Analysis of the role of endogenous TNF in endotoxin induced hemorrhagic necrosis and regression of an established sarcoma. J Exp Med 1988; 167: 1086–1099.
  • Geran RI, Greenberg NH, MacDonald MM, Schumacher AM, Abbott BJ. Protocols for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemother Rep 1972; 3(pt.3): 15.
  • Houghton PJ, Taylor DM. Fractional incorporation of 3 [H]- thymidine and DNA specific activity as assays of inhibition of tumor growth. Br J Cancer 1977; 35: 68–77.
  • Sava G, Ceschia V, Pacor S, Zabucchi G. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma. Anticancer Res 1991; 11: 1109–1113.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.